Chemotherapy Market Report 2026

Chemotherapy Market Overview

• Chemotherapy market size has reached to $37.27 billion in 2025 • Expected to grow to $68.44 billion in 2030 at a compound annual growth rate (CAGR) of 13% • Growth Driver: Increasing Cancer Prevalence Drives Growth Of Chemotherapy Market • Market Trend: Strategic Commercialization Of Innovative Chemotherapy Support Device • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chemotherapy Market?

Chemotherapy refers to a treatment using drugs or medicines that kill the fast-growing cells in the body by using powerful chemicals. The drugs can be used in combination or alone for the treatment of cancer. They are used to treat cancer, as cancer cells grow at a fast rate. The main product types of chemotherapy are pumps, cannulas, catheters, and other types. Pumps are chemotherapy infusion pumps that are attached to the patient and deliver a controlled number of drugs slowly into the patient's bloodstream. The main services involved are blood cancer, throat cancer, lung cancer, ovarian cancer, and stomach cancer by using alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and other drugs that are delivered through oral and intravenous routes and are used in end-users such as hospitals, research institutes, and other end-users.

What Is The Chemotherapy Market Growth Forecast?

The chemotherapy market size is expected to see rapid growth in the next few years. It will grow to $68.44 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to expansion of precision medicine, development of targeted therapies, increasing awareness about home-based chemotherapy, integration of digital health solutions, rising demand for combination therapies. Major trends in the forecast period include personalized chemotherapy regimens, oral chemotherapy adoption, combination drug therapy development, home-based chemotherapy delivery, advanced infusion device technologies.

Global Chemotherapy Market Segmentation

1) By Product Type: Pump, Cannula, Catheter, Other Product Types 2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer 3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs 4) By Route Of Administration: Oral, Intravenous 5) By End User: Hospitals, Research Institutes, Other End Users Subsegments: 1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps 2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports 3) By Catheter: Chemotherapy Catheters, PICC Lines 4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

What Is The Driver Of The Chemotherapy Market?

The increasing cancer prevalence is expected to propel the growth of the chemotherapy market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. In chemotherapy powerful chemicals are used in combination or alone for the treatment of cancer by killing fast-growing cancer cells. In addition, increasing cancer prevalence will increase the demand for chemotherapy. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, in 2025, over 35 million new cancer cases are predicted, a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing cancer prevalence is driving the chemotherapy industry.

Key Players In The Global Chemotherapy Market

Major companies operating in the chemotherapy market are GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

Global Chemotherapy Market Trends and Insights

Major companies operating in the chemotherapy market are focused on adopting strategic partnerships to commercialize the launch of innovative medical devices aiding in chemotherapy services. These partnerships aim to leverage the strengths and resources of each party to accelerate breakthroughs in cancer treatment, improve patient outcomes, and address unmet medical needs. For instance, in March 2023, EVERSANA, a US-based provider of global services to the life sciences industry, partnered with ChemoMouthpiece LLC, a US-based medical device company, to support the launch and commercialization of its medical device, the Chemo Mouthpiece, to assist oncology patients across the United States. The Chemo Mouthpiece is an intraoral ice pack that delivers cryotherapy to the oral cavity of a patient receiving chemotherapy. It prevents and cures oral mucositis, a common and excruciating chemotherapy side effect.

What Are Latest Mergers And Acquisitions In The Chemotherapy Market?

In February 2024, AbbVie, a US-based biopharmaceutical company, acquired ImmunoGen for $10.1 billion. This acquisition is expected to enhance AbbVie's oncology portfolio by integrating ImmunoGen's innovative antibody-drug conjugate technology. With this strategic move, AbbVie aims to expand its capabilities in developing advanced treatments for patients battling various types of cancer. ImmunoGen is a US-based company developing chemotherapy drugs.

Regional Insights

North America was the largest region in the chemotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chemotherapy Market?

The chemotherapy market includes revenues earned by entities by providing corticosteroids and hormonal agents as chemotherapy drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chemotherapy Market Report 2026?

The chemotherapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chemotherapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.